Latest Disclosure Policy News

DTI Group Ltd has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed information behind the market activity.

Novo Resources has responded to an ASX price query, attributing recent share price and volume spikes to insider buying and rising gold prices, while confirming no undisclosed material information.

Insignia Financial has responded to ASX concerns over past disclosures of performance rights, affirming shareholder approvals and outlining improved compliance measures.

NEXTDC has responded to ASX concerns over early media disclosures about its $7 billion OpenAI data centre deal, affirming compliance with continuous disclosure rules and downplaying price sensitivity.

Cauldron Energy’s CEO posted a video during a trading halt that prematurely hinted at exploration results, breaching ASX disclosure rules. The company acknowledges the misstep and outlines steps to tighten compliance.

Sequoia Financial Group has acknowledged that ASIC’s civil penalty proceedings against its subsidiary InterPrac are material and confirmed timely disclosure to the market following formal notification.

Lodestar Minerals has responded to ASX queries clarifying the timing and disclosure of key assay results from its Ned’s Creek gold project and detailed the procedural steps behind its Arizona Mountain Pass rare earths acquisition.

Stealth Group Holdings has explained the late filing of a director’s interest notice as an administrative oversight, assuring no market harm occurred. The company has since strengthened its compliance controls to prevent future lapses.

DroneShield Limited has clarified the recent sharp decline in its share price, attributing the market movement to disclosed director share disposals rather than any undisclosed material information.

Altech Batteries confirms the strategic importance of its AMPower Agreement, enabling immediate sales and cash flow, while detailing a recent $6 million capital raising and addressing trading compliance issues.

Clarity Pharmaceuticals has responded to ASX queries clarifying the timing and materiality of its SAR-bisFAP data presentation, denying the information was price sensitive despite a notable share price rise.

Cazaly Resources has addressed a sharp rise in its share price and trading volume, attributing the movement to strong gold and silver prices alongside a recent independent research report.